BioSpace News Archive

AxoGen Announces Closing of Public Offering of Common Stock

The total net proceeds from the offering for AxoGen are estimated to be approximately $15.4 million

November 20, 2017
·
5 min read
Business

Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017

The company’s revenues for the third quarter of 2017 increased by 27% over the revenues in the second quarter of 2017.

November 20, 2017
·
3 min read
Genetown

T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017

These data highlight the potential clinical value that may be achieved using the T2Bacteria Panel compared to results from blood culture.

November 20, 2017
·
6 min read
Zealand Increases Its Share Capital as a Consequence of Exercise of Employee Warrants - Nov. 20, 2017

The exercise price was DKK 87.45 per share and the total proceeds to Zealand from the capital increase amount to DKK 218,625.00.

November 20, 2017
·
2 min read
Biotech Bay

“Hair for the Holidays” Social Media Campaign Drives Increased Patient Awareness and New Patient Inquiries for the ARTAS Robotic Hair Restoration System

The campaign, which is running from September to December, includes targeted, direct-to-patient advertising for robotic hair restoration with the ARTAS System on Facebook and Twitter.

November 20, 2017
·
1 min read
Drug Development

Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes

Imetelstat is a telomerase inhibitor initially developed by Geron and exclusively licensed to Janssen Biotech, Inc. (Janssen) on a worldwide basis.

November 20, 2017
·
5 min read
Business

Optinose to Report Third Quarter 2017 Financial Results and Operational Highlights on November 27, 2017

Optinose is a specialty pharmaceutical company on a mission to improve lives with a focus on patients cared for by ENT and allergy specialists.

November 20, 2017
·
1 min read
Deals

AmerisourceBergen Pays $815M Cash for Drug Wholesaler H. D. Smith

AmerisourceBergen expects the transaction to slightly add to its adjusted earnings per share in the current fiscal year.

November 20, 2017
·
11 min read
Business

IBEX Reports Results for the Year Ended July 31, 2017

Revenues for the year ended July 31, 2017 totaled $5,326,721 compared to $4,113,694 in the prior year.

November 20, 2017
·
5 min read
Lone Star Bio

Nexeon MedSystems Provides Shareholder Update

The Company highlights the following key activities that occurred during third quarter of 2017.

November 20, 2017
·
2 min read